Yingying Sang

机构：Optimal Solutions (United States) · ORCID：0000-0002-6179-7864

发表论文 214 篇 · 总被引 14289 次 · h-index 55

代表论文

• Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes (2025 · JAMA · 被引 18)
• Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data (2025 · American Journal of Kidney Diseases · 被引 9)
• Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk (2025 · Annals of Internal Medicine · 被引 6)
• Peripheral artery disease and risk of kidney outcomes: The Atherosclerosis Risk in Communities (ARIC) study (2024 · Atherosclerosis · 被引 6)
• Arterial Stiffness and Subsequent Incidence of CKD and Kidney Function Decline in a Large Longitudinal Community Cohort: The Atherosclerosis in Communities (ARIC) Study (2025 · American Journal of Kidney Diseases · 被引 5)
• Incorporation of Cystatin C Testing in Clinical Practice: Real World Experience in Sweden (2024 · Kidney International Reports · 被引 3)